Otto Soepenberg
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
Papers in
- Oncology 5
- Lung Cancer Research Studies 4
- Neutropenia and Cancer Infections 2
- Cancer Treatment and Pharmacology 1
-
- Cancer therapeutics and mechanisms 6
- Co-authors
- Jaap Verweij (9 shared papers)Alex Sparreboom (8 shared papers)Walter J. Loos (3 shared papers)Diederik F.S. Kehrer (1 shared paper)Maja J.A. de Jonge (5 shared papers)Ferry A.L.M. Eskens (3 shared papers)Murray P. Ducharme (1 shared paper)Jantien Wanders (1 shared paper)
- Journals
- Annals of Oncology (2 papers)Clinical Cancer Research (2 papers)European Journal of Cancer (2 papers)The Alkaloids. Chemistry and biology (1 paper)Journal of Chromatography B (1 paper)
- Partner nations
- NetherlandsBelgiumUnited Kingdom
In The Last Decade
Otto Soepenberg
12 papers receiving 342 citations
Peers
Comparison fields: 5 of 54
- Biomaterials 120
- Toxicology 25
- Oncology 121
- Pharmaceutical Science 27
- Molecular Medicine 20
Countries citing papers authored by Otto Soepenberg
This map shows the geographic impact of Otto Soepenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Otto Soepenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Otto Soepenberg more than expected).
Fields of papers citing papers by Otto Soepenberg
This network shows the impact of papers produced by Otto Soepenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Otto Soepenberg. The network helps show where Otto Soepenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Otto Soepenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 102 | |
| 2 | 2005 | 76 | |
| 3 | 2005 | 68 | |
| 4 | 2004 | 32 | |
| 5 | 2005 | 25 | |
| 6 | 2007 | 21 | |
| 7 | 2003 | 13 | |
| 8 | 1994 | 9 | |
| 9 | 2017 | 9 | |
| 10 | 2003 | 7 | |
| 11 | 2011 | 2 | |
| 12 | 2003 | 1 |
About Otto Soepenberg
Otto Soepenberg is a scholar working on Oncology, Molecular Biology, Family Practice, Toxicology and Hematology, having authored 12 papers that have together received 365 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (6 papers), Lung Cancer Research Studies (4 papers), Neutropenia and Cancer Infections (2 papers), Acute Myeloid Leukemia Research (1 paper), Cancer Genomics and Diagnostics (1 paper), Antibiotics Pharmacokinetics and Efficacy (1 paper), Bioactive Compounds and Antitumor Agents (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Biomaterials (120 citations), Toxicology (25 citations), Oncology (121 citations), Pharmaceutical Science (27 citations) and Molecular Medicine (20 citations). Otto Soepenberg has collaborated with scholars based in Netherlands, Belgium and United Kingdom. Frequent co-authors include Jaap Verweij, Alex Sparreboom, Walter J. Loos, Diederik F.S. Kehrer, Maja J.A. de Jonge, Ferry A.L.M. Eskens, Murray P. Ducharme, Jantien Wanders, Peter Cheverton and Sylvie Assadourian. Their work appears in journals such as Annals of Oncology, Clinical Cancer Research, European Journal of Cancer, The Alkaloids. Chemistry and biology and Journal of Chromatography B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.